Concepedia

Wanqi Yang

WY

Statistics

Publications

31

Citations

1.8K

H-Index

17

Active since

2012

Affiliations

University of Electronic Science and Technology of China(Current)

Huzhou University

Heilongjiang Academy of Sciences

Harbin Medical University

Sinovac Biotech

Wanqi Yang is an author at University of Electronic Science and Technology of China specializing in medicine, cell biology, and cardiology.

ORCID

Top concepts

Publications per year

2012–2025

31

Publications

31

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zhiwei Wu, Yaling Hu, Miao Xu et al. · The Lancet Infectious Diseases · 2021 · 572 citations · Full text

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

Bihua Han, Yufei Song, Changgui Li et al. · The Lancet Infectious Diseases · 2021 · 351 citations · Full text

, , +8

Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts

Tingting Li, Yuting Zhuang, Wanqi Yang et al. · The FASEB Journal · 2020 · 141 citations

Enhanced uptake and transport of (+)-catechin and (-)-epigallocatechin gallate in niosomal formulation by human intestinal Caco-2 cells

Qinxin Song, Danhui Li, Yongzhi Zhou et al. · International Journal of Nanomedicine · 2014 · 97 citations · Full text

Strategic Design of Catalytic Lysine‐Targeting Reversible Covalent BCR‐ABL Inhibitors**

David Quach, Guanghui Tang, Jothi Anantharajan et al. · Angewandte Chemie International Edition · 2021 · 76 citations

1–5 of 31